Advisory Services Network’s ADMA Biologics ADMA Stock Holding History

Advisory Services Network’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,637	Closed	-$23.8K	–	2194
2026 Q1	$23.8K	Buy	+2,637	New	+$41.6K	﹤0.01%	3097
2025 Q4	–	Sell	-1,543	Closed	-$22.6K	–	1831
2025 Q3	$22.6K	Buy	+1,543	New	+$26.4K	﹤0.01%	2891
2023 Q2	–	Sell	-500	Closed	-$1.66K	–	1456
2023 Q1	$1.66K	Hold	500	–	–	﹤0.01%	3488
2022 Q4	$1.94K	Buy	+500	New	+$1.54K	﹤0.01%	3442
2021 Q3	–	Sell	-500	Closed	-$1K	–	1404
2021 Q2	$1K	Buy	+500	New	+$880	﹤0.01%	3410
2021 Q1	–	Sell	-1,500	Closed	-$3K	–	1301
2020 Q4	$3K	Buy	+1,500	New	+$3.15K	﹤0.01%	2843
2020 Q2	–	Sell	-3,000	Closed	-$9K	–	1069
2020 Q1	$9K	Hold	3,000	–	–	﹤0.01%	2223
2019 Q4	$12K	Buy	3,000 +1,000	+50%	+$4.36K	﹤0.01%	2252
2019 Q3	$8K	Hold	2,000	–	–	﹤0.01%	2237
2019 Q2	$8K	Hold	2,000	–	–	﹤0.01%	2235
2019 Q1	$8K	Hold	2,000	–	–	﹤0.01%	1912
2018 Q4	$5K	Hold	2,000	–	–	﹤0.01%	1994
2018 Q3	$12K	Sell	2,000 -750	-27%	-$4.32K	﹤0.01%	1750
2018 Q2	$17K	Buy	2,750 +1,050	+62%	+$5.23K	﹤0.01%	1592
2018 Q1	$8K	Buy	1,700 +1,000	+143%	+$3.98K	﹤0.01%	1934
2017 Q4	$2K	Buy	+700	New	+$1.96K	﹤0.01%	2333

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Advisory Services Network's ADMA Position: Q2 2026 in Review

Advisory Services Network sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 2,637 shares — an estimated $23.8K sold.

Advisory Services Network first reported a position in ADMA in Q4 2017 and held it in 16 quarters. The position peaked at $23.8K in Q1 2026. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Advisory Services Network reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 2,637 ADMA Biologics shares in Q2 2026, an estimated $23.8K.
Advisory Services Network first reported a position in ADMA Biologics in Q4 2017 and held it in 16 quarters.
Advisory Services Network's ADMA Biologics position peaked at $23.8K in Q1 2026.
323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.